Print ISSN: 2394-2746
Online ISSN: 2394-2754
CODEN : IJOGCS
Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...Original Article
Author Details :
Volume : 6, Issue : 2, Year : 2019
Article Page : 137-140
https://doi.org/10.18231/j.ijogr.2019.032
Abstract
Introduction: Dysfunctional Uterine Bleeding, is Abnormal uterine bleeding in the absence of organic, systemic, iatrogenic cause.1 Norethisterone acetate is commoly used progesterone derivative for management.2 Ormeloxifene, a selective estrogen receptor modulator is an another alternate treatment for DUB.3 Study was conducted at MVJ Medical College Bangalore.
Objective: to compare treatment efficacy and usefulnes of Ormeloxifene and oral progesterone in DUB treatment.
Materials and Methods: Total of 60 perimenopausal women with DUB were enrolled in our prospective study. They were randomly assigned to group A and group B.
Group A: 30 women with DUB were treated with 60mg Ormeloxifene two times a week for 3 months, 60mg weekly once for next 3 months.
Group B: Norethisterone 5 mg two times a day for 21 days for 6 cycles.
Results: In our study even though Norethistrone group showed significant reduction in blood loss and also increase in haemoglobin level, these results were significantly less when compared with Ormeloxifene group.
In addition Ormeloxifene group showed significant reduction in endometrial thickness, which was not significantly reduced in Norethisterone group. As a result of significant reduction of endometrial thickness among the women treated with Ormeloxifene.
Conclusion: In the study Ormeloxifene was found to be effective than Norethisterone in reducing blood loss, improving Haemoglobin level and reducing endometrial thickness for treating DUB patients. Also compliance of the patients was good because drug was well tolerated, convenient dosage schedule for treatment of DUB.
Keywords: Ormeloxifene, Norethisterone, Haemoglobin, Endometrial thickness, PBAC.
How to cite : Surabhi Hd, Chandra Mouli A, Comparison of effectiveness of ormeloxifene with norethisterone in perimenopausal DUB treatment. Indian J Obstet Gynecol Res 2019;6(2):137-140
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.